Steward Partners Investment Advisory, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 21,323 shares of LXRX stock, worth $18,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,323
Previous 400
5230.75%
Holding current value
$18,764
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$120 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$8.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$8.41 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$7.23 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$3.25 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $166M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...